ESR1 and breast carcinoma: Similarly a non-significant correction was revealed between VEGF-A (-460T>C) genotypes of breast cancer cases with estrogen receptor as well as progesterone receptor status (P=0.63 and 0.34) whereas a significant correction was revealed with respect to her2/neu receptor status (P=0.001) as depicted in Table 5.